Cargando…
Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma
Despite of the discovery of protein therapeutic targets and advancement in multimodal therapy, the survival chance of high-risk neuroblastoma (NB) patients is still less than 50%. MYCN amplification is a potent driver of NB, which exerts its oncogenic activity through either activating or inhibiting...
Autores principales: | Sahu, Divya, Hsu, Chia-Lang, Lin, Chen-Ching, Yang, Tz-Wen, Hsu, Wen-Ming, Ho, Shinn-Ying, Juan, Hsueh-Fen, Huang, Hsuan-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295409/ https://www.ncbi.nlm.nih.gov/pubmed/27517149 http://dx.doi.org/10.18632/oncotarget.11158 |
Ejemplares similares
-
High-risk, Expression-Based Prognostic Long Noncoding RNA Signature in Neuroblastoma
por: Sahu, Divya, et al.
Publicado: (2018) -
LncRNA SNHG1 regulates neuroblastoma cell fate via interactions with HDAC1/2
por: Hsu, Chia-Lang, et al.
Publicado: (2022) -
Unveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data
por: Hsu, Chia-Lang, et al.
Publicado: (2016) -
Identification and characterization of the lncRNA signature associated with overall survival in patients with neuroblastoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2019) -
Stratification of lncRNA modulation networks in breast cancer
por: Yu, Wen-Hsuan, et al.
Publicado: (2022)